TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
Chronic Refractory Cough Market is Expected to Boom by 2034 Driven by Advancements in Treatment Options | DelveInsight

The chronic refractory cough market is projected to expand by 2034, driven by rising patient diagnoses, improved awareness, and emerging therapies targeting refractory cough conditions.

Insights
JPMpM   positive

Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising


GSK   positive

Developing camlipixant, a promising P2X3 receptor antagonist with Phase III trials and potential regulatory submission in 2026